Crohn’s Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70

4 years ago

Crohn’s Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70

James E. Melnyk, Mackenzie L. Lauro, Catherine L. Grimes, Ching-Wen Hou, Vishnu Mohanan, Amy K. Schaefer, Jason M. Burch, Hannah C. Wastyk

Nod2 is a cytosolic, innate immune receptor responsible for binding to bacterial cell wall fragments such as muramyl dipeptide (MDP). Upon binding, subsequent downstream activation of the NF-κB pathway leads to an immune response. Nod2 mutations are correlated with an increased susceptibility to Crohn’s disease (CD) and ultimately result in a misregulated immune response. Previous work had demonstrated that Nod2 interacts with and is stabilized by the molecular chaperone Hsp70. In this work, it is shown using purified protein and in vitro biochemical assays that the critical Nod2 CD mutations (G908R, R702W, and 1007fs) preserve the ability to bind bacterial ligands. A limited proteolysis assay and luciferase reporter assay reveal regions of Hsp70 that are capable of stabilizing Nod2 and rescuing CD mutant activity. A minimal 71-amino acid subset of Hsp70 that stabilizes the CD-associated variants of Nod2 and restores a proper immune response upon activation with MDP was identified. This work suggests that CD-associated Nod2 variants could be stabilized in vivo with a molecular chaperone.

Publisher URL: http://dx.doi.org/10.1021/acs.biochem.7b00470

DOI: 10.1021/acs.biochem.7b00470